Signaling Pathways - Renal Cancer - Bacterial Infectios - Chronic Myeloproliferative Disorders - Bladder Cancer
清除全部
- B2295 Pirarubicin1 Citation中文名: 吡柔比星Target: TopoisomerasesSummary: 拓扑异构酶II抑制剂,蒽环类抗生素
- B1858 Tranexamic Acid中文名: 氨甲环酸Target: fibrinolysisSummary: 纤溶酶原激活的竞争性抑制剂
- B1474 FT-207 (NSC 148958)中文名: 替加氟Summary: DNA/RNA合成抑制剂
- B1321 OTSSP167Target: MELKSummary: MELK抑制剂
- B1642 WYE-125132 (WYE-132)Target: mTORSummary: mTOR抑制剂
- A1987 Ki164254 CitationTarget: LPA ReceptorsSummary: LPA受体拮抗剂
- A2168 Dovitinib (TKI-258, CHIR-258)2 Citation中文名: 多韦替尼Target: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 多靶点RTK抑制剂
- A8245 Sorafenib Tosylate1 Citation中文名: 甲苯磺酸索拉非尼Target: Raf|VEGFRSummary: Raf激酶和酪氨酸激酶抑制剂
- A8215 PP 1Target: Src|EGFR|JAK|ZAP-70Summary: Src家族酪氨酸激酶抑制剂
- A8219 Gefitinib (ZD1839)3 Citation中文名: 吉非替尼Target: EGFRSummary: EGFR抑制剂